- Home
- SMHI vs FENC Comparison
SMHI vs FENC Comparison
Compare SMHI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMHI
- FENC
- Stock Information
- Founded
- SMHI 1989
- FENC 1996
- Country
- SMHI United States
- FENC United States
- Employees
- SMHI N/A
- FENC N/A
- Industry
- SMHI Marine Transportation
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMHI Consumer Discretionary
- FENC Health Care
- Exchange
- SMHI Nasdaq
- FENC Nasdaq
- Market Cap
- SMHI 189.9M
- FENC 156.9M
- IPO Year
- SMHI N/A
- FENC 2001
- Fundamental
- Price
- SMHI $6.85
- FENC $5.76
- Analyst Decision
- SMHI
- FENC Strong Buy
- Analyst Count
- SMHI 0
- FENC 2
- Target Price
- SMHI N/A
- FENC $14.00
- AVG Volume (30 Days)
- SMHI 162.3K
- FENC 68.3K
- Earning Date
- SMHI 02-27-2025
- FENC 11-07-2024
- Dividend Yield
- SMHI N/A
- FENC N/A
- EPS Growth
- SMHI N/A
- FENC N/A
- EPS
- SMHI N/A
- FENC N/A
- Revenue
- SMHI $274,636,000.00
- FENC $49,348,000.00
- Revenue This Year
- SMHI $6.04
- FENC $170.43
- Revenue Next Year
- SMHI $11.18
- FENC $6.70
- P/E Ratio
- SMHI N/A
- FENC N/A
- Revenue Growth
- SMHI 3.89
- FENC 278.09
- 52 Week Low
- SMHI $5.80
- FENC $3.96
- 52 Week High
- SMHI $15.36
- FENC $11.49
- Technical
- Relative Strength Index (RSI)
- SMHI 49.67
- FENC 51.31
- Support Level
- SMHI $6.90
- FENC $5.47
- Resistance Level
- SMHI $7.28
- FENC $6.19
- Average True Range (ATR)
- SMHI 0.34
- FENC 0.25
- MACD
- SMHI 0.04
- FENC -0.06
- Stochastic Oscillator
- SMHI 37.25
- FENC 38.99
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides world-wide marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations including wind farms; handle anchors and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico); Africa and Europe; Middle East and Asia and Latin America.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.